Published in Eur J Heart Fail on August 05, 2005
Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab (2011) 1.50
Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: review of the literature and clinical recommendations. Can J Cardiol (2007) 0.87
N-terminal pro-B-type natriuretic Peptide in overweight and obese patients with and without diabetes: an analysis based on body mass index and left ventricular geometry. Korean Circ J (2009) 0.83
Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes. Obesity (Silver Spring) (2011) 0.83
Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults. PLoS One (2014) 0.83
Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension. Heart Vessels (2015) 0.82
RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy. PLoS One (2014) 0.82
Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment. Cardiovasc Diabetol (2009) 0.77
Impact of body mass index on plasma N-terminal ProB-type natriuretic peptides in Chinese atrial fibrillation patients without heart failure. PLoS One (2014) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. J Am Coll Cardiol (2004) 2.60
[An invasive strategy in non-ST-segment elevation acute coronary syndromes. From large trials to the real world]. Rev Esp Cardiol (2004) 2.03
[Fabry disease from the neurologist's point of view: is it a rare cause of strokes?]. Rev Neurol (2015) 1.97
Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells (2007) 1.68
[Use of sirolimus-eluting stents in complex lesions: clinical and angiographic follow-up]. Rev Esp Cardiol (2004) 1.60
The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J (2008) 1.60
Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices. Heart Rhythm (2011) 1.52
Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Thromb Haemost (2015) 1.49
Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol (2010) 1.47
Morphological evidence of muscular connections between contiguous pulmonary venous orifices: relevance of the interpulmonary isthmus for catheter ablation in atrial fibrillation. Heart Rhythm (2009) 1.46
[Emergency room risk stratification of patients with chest pain without ST segment elevation]. Rev Esp Cardiol (2003) 1.46
Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial. Eur Heart J (2006) 1.44
[Annexin V levels in survivors of early myocardial infarction]. Rev Esp Cardiol (2002) 1.44
Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial. Eur Heart J (2005) 1.42
Capillary supply to the sinus node in subjects with long-term atrial fibrillation. Ann Thorac Surg (2010) 1.42
Does pacemaker implantation provide long-term benefits in severe obstructive hypertrophic cardiomyopathy? Rev Esp Cardiol (2009) 1.41
Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4. Endocrinology (2013) 1.41
[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol (2007) 1.41
[Myocardial echocardiography with intracoronary injection of contrast in post-infarction patients. Implications and comparison with angiography and magnetic resonance imaging]. Rev Esp Cardiol (2004) 1.40
How close are the phrenic nerves to cardiac structures? Implications for cardiac interventionalists. J Cardiovasc Electrophysiol (2005) 1.40
Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) (2009) 1.40
[Long-term prognosis of serum and urine n-terminal proBNP levels and glomerular filtration rate in heart failure patients]. Med Clin (Barc) (2009) 1.40
[Non-invasive assessment of coronary artery bypass grafts by computed tomography: comparison with conventional coronary angiography]. Rev Esp Cardiol (2005) 1.40
[Non-invasive coronary angiography with 16 multidetector-row spiral computed tomography: a comparative study with invasive coronary angiography]. Rev Esp Cardiol (2004) 1.40
[Sex differences in mortality at one-month and at one-year after an acute coronary syndrome]. Med Clin (Barc) (2004) 1.39
[Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients]. Rev Esp Cardiol (2005) 1.38
Blood pressure control in hypertensive women aged 65 years or older in a primary care setting. MERICAP study. Rev Esp Cardiol (2011) 1.38
Anatomic relations between the esophagus and left atrium and relevance for ablation of atrial fibrillation. Circulation (2005) 1.38
[Relationship between echocardiographic abnormalities and sleep apnea-hypopnea syndrome severity]. Rev Esp Cardiol (2007) 1.37
Implantation of single-lead atrioventricular permanent pacemakers guided by electroanatomic navigation without the use of fluoroscopy. Europace (2008) 1.30
Comparison of effectiveness of right ventricular septal pacing versus right ventricular apical pacing. Am J Cardiol (2010) 1.20
MR imaging of ligament and tendon injuries of the fingers. Radiographics (2002) 1.18
Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study. Cardiology (2006) 1.13
Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res (2010) 1.08
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway. Cell Mol Life Sci (2012) 0.99
Longitudinal study of hepatitis E virus infection in Spanish farrow-to-finish swine herds. Vet Microbiol (2010) 0.98
[Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance]. Rev Esp Cardiol (2011) 0.97
Subjective symptoms related to GSM radiation from mobile phone base stations: a cross-sectional study. BMJ Open (2013) 0.96
Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytes. Cardiovasc Res (2009) 0.95
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol (2010) 0.95
Topiramate in the prophylactic treatment of cluster headache. Headache (2003) 0.94
Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices. Europace (2010) 0.93
Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail (2010) 0.93
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. Eur J Intern Med (2011) 0.92
Anatomic evaluation of the left phrenic nerve relevant to epicardial and endocardial catheter ablation: implications for phrenic nerve injury. Heart Rhythm (2009) 0.92
Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices. Europace (2011) 0.91
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
[Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction]. Rev Esp Cardiol (2004) 0.90
Technical reliability and clinical safety of a remote monitoring system for antiarrhythmic cardiac devices. Rev Esp Cardiol (2009) 0.90
Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant (2004) 0.89
Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology. PLoS One (2012) 0.89
Increased expression of fatty-acid and calcium metabolism genes in failing human heart. PLoS One (2012) 0.88
Prenatal ethanol exposure alters the cytoskeleton and induces glycoprotein microheterogeneity in rat newborn hepatocytes. Alcohol Alcohol (2004) 0.88
Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure. J Card Fail (2011) 0.87
Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens (2009) 0.87
Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue. J Cell Mol Med (2012) 0.87
Heart failure induces significant changes in nuclear pore complex of human cardiomyocytes. PLoS One (2012) 0.87
Thrombocytopenia associated with levodopa treatment. Arch Intern Med (2003) 0.87
[Acute myocardial infarction in patients under 45 years]. Rev Esp Cardiol (2002) 0.87
Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels. Am J Hypertens (2008) 0.86
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1? Stroke (2003) 0.86
Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol (2005) 0.86
Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart (2007) 0.86
Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. Am J Cardiol (2006) 0.86
Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coron Artery Dis (2010) 0.86
Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. Int J Cardiol (2013) 0.85
ASK1 overexpression accelerates paraquat-induced autophagy via endoplasmic reticulum stress. Toxicol Sci (2010) 0.85
Recurrent pericarditis in a patient with ulcerative proctitis due to mesalazine suppositories. Int J Colorectal Dis (2010) 0.85
ATP synthase subunit alpha and LV mass in ischaemic human hearts. J Cell Mol Med (2014) 0.84
Inflammatory markers in stable heart failure and their relationship with functional class. Int J Cardiol (2007) 0.84
Complete regression of cardiac non-Hodgkin lymphoma. Int J Cardiol (2006) 0.84
Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. Int J Cardiol (2010) 0.84
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol (2009) 0.84
Differential gene expression of cardiac ion channels in human dilated cardiomyopathy. PLoS One (2013) 0.84
Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. Rev Esp Cardiol (Engl Ed) (2012) 0.83
Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail (2006) 0.83
Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study. PLoS One (2012) 0.83